好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Spreading Depolarization Burden Association With Neurological Recovery Following Traumatic Brain Injury
Neuro Trauma and Critical Care
S21 - Neurocritical Care (2:48 PM-3:00 PM)
010

To evaluate the association of spreading depolarizations (SD) after acute traumatic brain injury (TBI) with neurological outcomes and post-traumatic epilepsy (PTE).

Spreading depolarizations are slow waves of electrical activity that propagate across large areas of the brain, affecting synaptic activity and cerebral blood flow. The role of SDs in secondary brain injury and epileptogenesis after TBI is not known.

Retrospective cohort including adult patients with TBI who had electrocorticography (ECoG) monitoring after cranial surgery for hematoma evacuation and had a Glasgow Coma Scale (GCS) score of ≤12. Strip and depth electrodes (4-16 channels) were implanted. Poor neurological outcome was defined as a Modified Rankin Scale (mRS) score of ≥4 at discharge. The definition of PTE was the presence of unprovoked seizures occurring ≥7 days post-TBI (up to 4-year follow-up). 

We included 119 patients, and 16 patients (13.4%) had SDs recorded on ECoG. The mean age was 52 years old (SD=19.0), and 76% male (n=91). Median ECoG length was 123 hours (IQR 92); monitoring began 23.5 hours post-TBI (IQR 7.33), and first SD occurred at 28 hours (IQR 47.6). Seizures occurred in 25 patients (21%), with 9 (56%) also experiencing SDs (p=0.001). Only one (6%) SD patient developed PTE. Mortality was 62.5% for SD patients and 33.6% without SDs (p=0.019). All SD patients had an mRS of ≥4. Higher frequency of SDs was associated with worse mRS (p=0.034, OR=1.215). Ten SD patients (62.5%) experienced SD clusters (3/2h), with a mean of 2.2 (median=1.33) clusters/day within 72 hours post-TBI. There was a trend between increasing cluster frequency and worse outcome (p=0.07, OR=2.75).

Spreading depolarization burden is associated with death and poor neurological outcomes. While SDs commonly co-occurred with seizures, their association with PTE could not be determined. Future multicenter studies with larger cohorts may help elucidate whether SD contribute to PTE development.

Authors/Disclosures
Adeline Hayman
PRESENTER
Ms. Hayman has nothing to disclose.
Kevin Bao Mr. Bao has nothing to disclose.
Xiaoyu Zhou, MA Mrs. Zhou has nothing to disclose.
Katherine Peterson Ms. Peterson has nothing to disclose.
Matheus Otero, MD (Mount Sinai West) Dr. Otero has nothing to disclose.
Anthony Mefford, MD (SFVA Medical Center) Dr. Mefford has nothing to disclose.
Roxanne L. Simmons, MD (UCSF) Dr. Simmons has nothing to disclose.
Vishnu Karukonda (University of California, San Francisco) Mr. Karukonda has nothing to disclose.
Lawrence Chyall, RN, MS, CNS Mr. Chyall has nothing to disclose.
Michael Huang, MD Dr. Huang has nothing to disclose.
Geoffrey Manley, MD, PhD (UCSF Med Ctr/Dept of Neurosurgery) The institution of Dr. Manley has received research support from NIH-NINDS. The institution of Dr. Manley has received research support from US Department of Defense. The institution of Dr. Manley has received research support from US Department of Defense/MTEC. The institution of Dr. Manley has received research support from One Mind. The institution of Dr. Manley has received research support from Neurotrauma Sciences, LLC. The institution of Dr. Manley has received research support from NFL Scientific Advisory Board.
David J. Caldwell, MD, PhD The institution of Dr. Caldwell has received research support from NIH.
John K. Yue, MD The institution of Dr. Yue has received research support from University of California San Francisco Weill Neurohub. The institution of Dr. Yue has received research support from University of California San Francisco Weill Institute for the Neurosciences and University of California San Francisco Innovation Ventures Catalyst Award Grant.
Claude Hemphill III, MD, FAAN (Zuckerberg San Francisco General Hospital) Dr. Hemphill has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll. Dr. Hemphill has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Aurenar. Dr. Hemphill has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Hemphill has received research support from NIH/NINDS.
Britta Lindquist, MD, PhD (UCSF Neurology) The institution of Dr. Lindquist has received research support from National Institutes of Health NINDS.
Edilberto Amorim, MD The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from Society of Critical Care Medicine. The institution of Dr. Amorim has received research support from Zoll Foundation. The institution of Dr. Amorim has received research support from Hellman Foundation. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from Citizens United Against Epilepsy. The institution of Dr. Amorim has received research support from Regents of the University of California. The institution of Dr. Amorim has received research support from American Heart Association. The institution of Dr. Amorim has received research support from NIH. The institution of Dr. Amorim has received research support from Department of Defense. The institution of Dr. Amorim has received research support from Department of Defense. The institution of Dr. Amorim has received research support from American Heart Association.